HER2xCD3 bispecific

abpro atlantic coastal acquisition corp merger, abpro antibody pipeline her2 covid, abpro spac deal valuation, abpro t-cell engager her2 cancer, abpro covid-19 antibody program, abpro nasdaq listing spac, abpro spac merger news

Abpro to go public via SPAC merger with Atlantic Coastal, raising funds for its HER2xCD3 bispecific and COVID-19 program

Anika Sharma

Abpro is making a return to the public market after a five-year hiatus, this time teaming up with Atlantic Coastal ...